Display of avian influenza virus nucleoprotein on Bacillus thuringiensis cell surface using CTC as a fusion partner.
The S-layer protein CTC surface display system of Bacillus thuringiensis was used to test the possibility of displaying avian influenza virus nucleoprotein (NP) on the cell surface of B. thuringiensis. By fusing np with the anchoring motif of ctc, four recombinant plasmids were constructed. They harbored fusion gene ctc-np, csa-ctc-np (csa representing csaAB operon, very important in anchoring S-layer protein on cell surface), ctc-npp (npp representing the part fragment of np), and csa-ctc-npp, respectively. Five recombinant strains were obtained by transferring recombinant plasmids to B. thuringiensis plasmid-free derivative strain BMB171. The vegetative cells of five strains were used as agglutinogens for slide agglutination assays. The assays showed recombinant NP proteins successfully displayed on the cell surface of five strains. After immunization of chickens with spores by oral route, all five strains elicited a humoral response to NP and exhibited immunogenicity as indicated by enzyme-linked immunosorbent assay (ELISA). ELISA also showed that one of five strains, CN (bearing csa-ctc-npp), exhibited the highest immunogenicity among five strains, which suggested that the best way of constructing ctc fusion gene was the csa-ctc-npp. The strategy developed in this study suggests the possibility of generating a heat-stable and oral veterinary vaccine with B. thuringiensis surface display system.
Liu
Mei
M
State Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University, Wuhan 430070, People's Republic of China. liumei@mail.hzau.edu.cn
Li
Shuyun
S
Hu
Sishun
S
Zhao
Changming
C
Bi
Dingren
D
Sun
Ming
M
D000372:Agglutination Tests / Q000662:veterinary; D000818:Animals; D000914:Antibodies, Viral / Q000097:blood; D001413:Bacillus thuringiensis / Q000235:genetics* / Q000276:immunology / Q000378:metabolism; D001426:Bacterial Proteins / Q000235:genetics* / Q000276:immunology / Q000378:metabolism; D002645:Chickens; D007114:Immunization / Q000662:veterinary; D007074:Immunoglobulin G / Q000097:blood; D009980:Influenza A virus / Q000235:genetics* / Q000276:immunology / Q000378:metabolism; D007252:Influenza Vaccines / Q000008:administration & dosage / Q000235:genetics / Q000378:metabolism; D008562:Membrane Glycoproteins / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D009698:Nucleoproteins / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D015202:Protein Engineering / Q000379:methods*; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D014764:Viral Proteins / Q000235:genetics / Q000276:immunology / Q000378:metabolism*
D000914:Antibodies, Viral; D001426:Bacterial Proteins; D007074:Immunoglobulin G; D007252:Influenza Vaccines; D008562:Membrane Glycoproteins; D009698:Nucleoproteins; D011993:Recombinant Fusion Proteins; C055764:S-layer proteins; D014764:Viral Proteins; C106697:protein CTC, Bacteria